CSRF in Sourcecodester Drug Recommendation System
CVE-2026-105706
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.
Vulnerability class: CSRF (Cross-Site Request Forgery)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- vuldb.com/vuln/413699 (vdb-entry)
- vuldb.com/vuln/413699/cti (signature, permissions-required)
- vuldb.com/cve/CVE-2026-105706 (third-party-advisory)
- vuldb.com/submit/992055 (third-party-advisory)
- github.com/hackliu/Vulnerability-Reports/blob/master/Drug-Recommender-Web-App/V… (exploit)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-105706?
- CVE-2026-105706 is a medium-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-Site Request Forgery (CSRF). CVSS score: 4.3/10. Published 2026-10-06.
- How severe is CVE-2026-105706?
- Medium severity. CVSS v3 base score is 4.3 out of 10.